Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Office of Reg Affairs reorg

Executive Summary

FDA's Office of Regulatory Affairs will realign the workload of the two remaining deputy associate commissioners for regulatory affairs following the departure of Deputy for Regulatory Operations Steve Niedelman. Deputy ACRA Diana Kolaitis will "take lead responsibility for the operational aspects of ORA's work, including the achievement of our inspections and laboratory work," the agency said June 22. The director of the Office of Regional Operations will report to Kolaitis. Deputy ACRA David Horowitz will lead strategic aspects, including setting priorities and developing policies, with the director of the Office of Enforcement reporting to him. Niedelman leaves FDA at the end of June to take the role of exec VP at Quintiles Consulting (1"The Pink Sheet" June 19, 2006, In Brief)...

Latest Headlines
See All
UsernamePublicRestriction

Register

PS047322

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel